TruMulti Women's Formula
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 18 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 200.01 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 249.99 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine K2 Source : Ménaquinone 7 | 40 mcg | 120 µg |
| Manganèse Source : Sulfate de manganèse (II) | 0.77 mg | 2,310 µg |
| Fer Source : Iron Amino Acid Chelate / Hydrolyzed vegetable protein | 6 mg | 18,000 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 3.93 mg AT | Not calculated |
| Bêta-carotène Source : bêta-carotène | 1,800 mcg | Not calculated |
| Chrome Source : Picolinate de chrome (III) | 66.67 mcg | 200.01 µg |
| Zinc Source : Aspartate de zinc | 3.67 mg | 11,010 µg |
| Molybdène Source : Molybdenum amino acid chelate | 15 mcg | 45 µg |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 2,400 mg Potency : 5 % Withanolides | 200 mg | Not calculated |
| Vanadium Source : Sulfate de vanadyle | 3.33 mg | Not calculated |
| Bore Source : Citrate de bore | 166.67 mcg | Not calculated |
| Vitamine C Source : Acide ascorbique | 83.33 mg | 249,990 µg |
| Cuivre Source : Sulfate de cuivre (II) | 0.3 mg | 900 µg |
| Calcium Source : Calcium carbonate | 33.33 mg | 99,990 µg |
| Riboflavine Source : Riboflavine | 5 mg | 15,000 µg |
| Vitamine B12 Source : Méthylcobalamine | 33.33 mcg | 99.99 µg |
| Acide pantothénique Source : D-Pantothénate de calcium | 1.67 mg | 5,010 µg |
| Magnésium Source : Aspartate de magnésium | 33.33 mg | 99,990 µg |
Non-medicinal ingredients
Rouge 40, tocotriénols, Mélange de concentré de tocophérol, Gélatine, Dioxyde de titane, Dioxyde de silicium, Rouge FD&C No. 3, Bleu FD&C n° 1, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | minimum: 19 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps (to) maintain/support immune function. Helps in energy metabolism/tissue formation/and bone development. Helps to maintain normal red blood cells. Helps to maintain normal metabolism of iron. Helps to maintain the body¿s ability to metabolize nutrients. Helps to maintain healthy bones/hair/nails/mucous membranes and/or skin. Source of Vitamin A to help maintain eyesight/skin/membranes/immune function. Source of vitamin A to help/helps in the development and maintenance of night vision. Source of vitamin A to help/maintain eyesight, skin, membranes and immune function/in the development and maintenance of night vision, bones and teeth. Helps in the development and maintenance of bones/cartilage/teeth and/or gums/ and in connective tissue formation Helps in wound healing. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Source of/An antioxidant that protects the fat in body tissues from oxidation. Helps in/Supports energy production. Helps (to) form red blood cells. Helps in the normal function of the immune system. Helps (to) maintain healthy metabolism. Helps (to) maintain normal muscle function (and tissue formation). Helps support bone health. Helps to maintain heart muscle function. Helps (to) produce and repair connective tissue. Provides support for healthy glucose metabolism. Helps to maintain normal blood glucose levels. Helps to form red blood cells and helps in their proper function. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Supports/Maintains good health. Contributes to maintaining general health. For maintaining general health. A factor in the maintenance of good health. Helps increase resistance to stress in individuals with a history of chronic stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Performance Enhancing Supplements LLC dba Physique Enhancing Science
- NPN or DIN-HM
- 80097699
- Status
- Inactive licence
- Licence date
- 19 March 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80097699
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Withania somnifera
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “TruMulti Women's Formula”, https://compoatlas.com/en/supplements/canada/80097699-trumulti-women-s-formula, updated 19 March 2020.